Electrolytic transdermal delivery of polypeptides

A - Human Necessities – 61 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

128/104, 167/159

A61N 1/30 (2006.01) A61K 9/00 (2006.01) A61M 37/00 (2006.01)

Patent

CA 1317879

ABSTRACT The invention comprises in combination: a) a polypeptide having from about three to about 20 peptide units in aqueous solution or suspension, and b) an electrolytic device for transdermal transport of the polypeptide to the bloodstream of the patient. It may be useful to enhance the transdermal delivery of the polypeptide by adding an aqueous cosolute/cosolvent with negative Setschenow constants. The electrolytic device preferably comprises a hydrophilic reservoir containing a supply of the aqueous polypeptide solution or suspension, an electric battery, two extended contacts, and optionally a semipermeable membrane between the reservoir and the patients skin. Representative polypeptides include oxytocin, angiotensin I, II, and III, substance P, vasopressin, lypressin, desmopressin, leuprolide acetate, antripeptin, and the like.

558558

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Electrolytic transdermal delivery of polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Electrolytic transdermal delivery of polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Electrolytic transdermal delivery of polypeptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1214778

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.